Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioGeneric Pharma
10th of Ramadan City, Sharqia, Egyptbiogenericpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
BioGeneric Pharma S.A.E. operates a modern biopharmaceutical manufacturing facility in Egypt focused on the development, production, analysis, and marketing of high-quality biosimilars, therapeutic recombinant proteins, and preventive vaccines. The company serves local needs as well as EMEA/FDA markets with an emphasis on cost-effective “off-patent” biologics. It has established robust manufacturing capabilities including robotic fill-finish lines for vials/cartridges/pre-filled syringes. BGP also engages in contract manufacturing/CDMO activities while pursuing R&D collaborations to expand its pipeline—recently initiating an mRNA vaccine technology transfer project.[1][2][3]
Clinical results are not publicly detailed; the company’s main commercial activity centers around biosimilar/biologic product supply rather than novel clinical-stage assets.
Pipeline breadth cannot be precisely determined from public data but includes multiple programs across protein therapeutics/vaccines/biosimilars.[2]
- Therapeutic areas
- Other
- Modalities
- Therapeutic recombinant proteinsPreventive vaccines[1][2][3][4][6]Biosimilars[1]mRNA (in development)[3]
- Industry
- Biotech
02
Partnerships
Pharco Corporation (“Ranked No.1” Egyptian pharma group)[2]Amoytop Biotech Company (“Listed in the Stock Market”, China)[2]Ongoing search for further partnerships including tech transfer/JVs/R&D collaboration/outlicensing partners.[2]
Beyond the preview
Go deeper on BioGeneric Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioGeneric Pharma.